Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Georges Sukkarieh, Sophie Bonnin, Georges Azar, Justine Lafolie, Anne-Sophie Alonso, Ozlem Erol, Justine Pineau, Hélène Villain, Jessica Guillaume, Emmanuel Auge, Alain Mingou, Raphael Lejoyeux, Vivien Vasseur & Martine Mauget-Faÿsse. (2023) Outcome of Patients Treated by Intravitreal Injections During the COVID-19 Lockdown: An Institutional Experience. Current Eye Research 48:7, pages 683-689.
Read now
Read now
Articles from other publishers (3)
Debdulal Chakraborty, Aniruddha Maiti, Jay U Sheth, Soumen Mondal, Subhendu Boral, Krishnendu Nandi, Tushar Kanti Sinha & Arnab Das. (2022) Brolucizumab in Neovascular Age-Related Macular Degeneration – Indian Real-World Experience: The BRAILLE Study – Fifty-Two-Week Outcomes. Clinical Ophthalmology Volume 16, pages 4303-4313.
Crossref
Crossref
Ian Pearce, Winfried Amoaku, Clare Bailey, Louise Downey, Richard Gale, Faruque Ghanchi, Robin Hamilton, Sajjad Mahmood, Geeta Menon, Jenny Nosek, James Talks & Yit Yang. (2022) The changing landscape for the management of patients with neovascular AMD: brolucizumab in clinical practice. Eye 36:9, pages 1725-1734.
Crossref
Crossref
Chang-Chi Weng, Ting-Yi Lin, Yi-Ping Yang, Yu-Jer Hsiao, Tzu-Wei Lin, Wei-Yi Lai, Yi-Ying Lin, Yu-Bai Chou, Tai-Chi Lin, Shih-Hwa Chiou, De-Kuang Hwang & Shih-Jen Chen. (2021) Modifications of intravitreal injections in response to the COVID-19 pandemic. Journal of the Chinese Medical Association 84:9, pages 827-832.
Crossref
Crossref